You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
FIBERGRAFT® Bioactive Bone Graft Substitutes
FIBERGRAFT bone graft substitutes are created from a matrix of bioactive glass fibres and microspheres. This matrix provides continuous porosity, direct connectivity, high surface area, and resorption rates consistent with bone formation.1-4
1. Data on file. Prosidyan Reports SR0002, SR0007, SR0008, SR0009, SR0010, SR0011, SR0012, SR0013, SR0020, SR0025, TR0032, SR0035, SR0036.
2. S. Bondre, C. Bagga, Prosidyan, Inc. Evaluation of the Nano-Crystalline Hydroxyapatite Forming ability of Novel Bioactive Glass Micro Fiber - Collagen Matrix. Podium presentation, SFB 2018 Annual Meeting, Atlanta, Georgia, April 11-13, 2018.
3. Walter Eisner. Bioactive Glass Cleared for Postero-Lateral Fusion. Orthopedics This Week. November 17, 2015.
4. Julian R. Jones. Review of bioactive glass: From Hench to hybrids. Acta Biomaterialia9 (2013) 4457–4486
For product details such as indications, contraindications, warnings, and precautions, please consult the IFU.
41 Spring Street #107
New Providence, NJ 07974
FIBERGRAFT is a registered trademark of Prosidyan, Inc.
The third-party trademarks used herein are trademarks of their respective owners.
© Johnson & Johnson Medical Limited 2021. All Rights Reserved.
This site is published by the DePuy Synthes Companies, which are solely responsible for its content.
This site is for visitors from United Kingdom.
The third party trademarks used herein are trademarks of their respective owners.